Caredx issues statement in patent infringement case

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the jury verdict in the patent litigation brought by natera, inc. (nasdaq: ntra). caredx was found to have not infringed on natera patent 10,655,180 (the ‘180 patent) and found to have infringed on natera patent 11,111,544 (the ‘5.
CDNA Ratings Summary
CDNA Quant Ranking